The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis
Open Access
- 1 January 2006
- journal article
- Published by Springer Science and Business Media LLC in Cost Effectiveness and Resource Allocation
- Vol. 4 (1), 20
- https://doi.org/10.1186/1478-7547-4-20
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adultsAIDS Care, 2006
- An investigation into the health-related quality of life of individuals living with HIV who are receiving HAARTAIDS Care, 2005
- Scaling up access to antiretroviral treatment in southern Africa: who will do the job?The Lancet, 2004
- Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?The Lancet, 2004
- Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.2003
- Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii PneumoniaArchives of Internal Medicine, 2002
- The estimation of a preference-based measure of health from the SF-36Journal of Health Economics, 2001
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- Cost effectiveness of highly active antiretroviral therapy in HIV-infected patientsAIDS, 1999
- The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African populationQuality of Life Research, 1996